Teleflex Incorporated $TFX Shares Sold by Vanguard Group Inc.

Key Points

• Vanguard trimmed its Teleflex stake by 0.8%, selling 37,795 shares and now owns 4,759,015 shares (10.77%) valued at about $580.8 million, while institutional investors hold 95.62% of the stock.
• Teleflex reported a sharp quarterly miss—EPS $1.93 vs. $3.73 expected and revenue $569M vs. $912.6M expected—with revenue down 28.5% year‑over‑year and a negative net margin of 30.56%, but management set FY2026 guidance of $6.25–$6.55 EPS.
• Analyst views are mixed: several recent upgrades (Raymond James, Needham, BofA) offset by a sell from Weiss, leaving a consensus rating of Hold and an average price target of $133.57 versus the recent share price near $120.

Vanguard Group Inc. decreased its stake in Teleflex Incorporated (NYSE:TFX - Free Report) by 0.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,759,015 shares of the medical technology company's stock after selling 37,795 shares during the period. Vanguard Group Inc. owned 10.77% of Teleflex worth $580,790,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the stock. Eos Management L.P. acquired a new position in shares of Teleflex in the 4th quarter valued at $3,763,000. Ruffer LLP purchased a new stake in Teleflex in the 4th quarter valued at $5,154,000. M&T Bank Corp raised its position in Teleflex by 1,102.7% in the 4th quarter. M&T Bank Corp now owns 49,262 shares of the medical technology company's stock valued at $6,012,000 after purchasing an additional 45,166 shares during the last quarter. Universal Beteiligungs und Servicegesellschaft mbH raised its position in Teleflex by 227.5% in the 4th quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 27,822 shares of the medical technology company's stock valued at $3,395,000 after purchasing an additional 19,327 shares during the last quarter. Finally, Waterfront Wealth Inc. purchased a new stake in Teleflex in the 4th quarter valued at $2,050,000. Institutional investors and hedge funds own 95.62% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts recently commented on the stock. Raymond James Financial upgraded shares of Teleflex from a "market perform" rating to an "outperform" rating and set a $128.00 price target for the company in a research report on Friday, March 27th. Needham & Company LLC upped their price target on shares of Teleflex from $138.00 to $147.00 and gave the company a "buy" rating in a research report on Thursday, February 26th. Bank of America upgraded shares of Teleflex from an "underperform" rating to a "neutral" rating and set a $135.00 price target for the company in a research report on Monday, April 13th. Zacks Research upgraded shares of Teleflex from a "strong sell" rating to a "hold" rating in a research report on Tuesday, April 28th. Finally, Weiss Ratings reiterated a "sell (d)" rating on shares of Teleflex in a research report on Friday, March 27th. Two analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $133.57.

Teleflex Stock Down 1.4%

Shares of Teleflex stock opened at $120.02 on Tuesday. The company has a market cap of $5.31 billion, a P/E ratio of -5.84, a PEG ratio of 0.88 and a beta of 0.82. The company has a debt-to-equity ratio of 0.81, a quick ratio of 2.01 and a current ratio of 2.54. Teleflex Incorporated has a one year low of $100.18 and a one year high of $139.67. The firm has a fifty day moving average of $118.74 and a two-hundred day moving average of $116.72.

Teleflex (NYSE:TFX - Get Free Report) last announced its quarterly earnings data on Thursday, February 26th. The medical technology company reported $1.93 EPS for the quarter, missing analysts' consensus estimates of $3.73 by ($1.80). The firm had revenue of $569.00 million for the quarter, compared to analysts' expectations of $912.57 million. Teleflex had a positive return on equity of 14.30% and a negative net margin of 30.56%.The firm's quarterly revenue was down 28.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $3.89 EPS. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. On average, analysts forecast that Teleflex Incorporated will post 6.77 earnings per share for the current year.

Teleflex Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 31st. Shareholders of record on Friday, March 6th were given a dividend of $0.34 per share. The ex-dividend date was Friday, March 6th. This represents a $1.36 dividend on an annualized basis and a yield of 1.1%. Teleflex's dividend payout ratio is presently -6.62%.

Teleflex Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company's offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.